In The Biosimilar Showdown, Amgen Positions To Dominate
Executive Summary
Amgen announced intentions to become a major biosimilar player, leveraging its manufacturing experience, a few years ago, and now expects to launch five biosimilars in the next few years, and is adding more to its stable of candidates.